Regorafenib After Failure of Lenvatinib in Patients With Unresectable HCC: The RELEVANT-HCC Trial

Clinical trial NCT07514429 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07514429
Sponsor: Ju Hyun Shim
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular Lenvatinib Treatment Failure

Start date: 2026-03-15
Primary completion: 2028-05-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.